Elevance Health, US0367521038

Elevance Health stock gains 3.20% to EUR 395.25 premarket

Published on 11/16/2026 at 08:11 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Elevance Health provides health benefits and care solutions across medical, digital, pharmaceutical and behavioral-health services. On Xetra, the stock closed at EUR 383.00 on Friday, November 13, 2026.

What Matters Before Trading

  • Elevance Health provides medical, digital, pharmaceutical, behavioral-health and clinical care solutions.
  • The company serves consumers, families and communities through its health benefits business.
Elevance Health, US0367521038, Illustration mit AI erstellt.

Elevance Health stock traded at EUR 395.25 on Lang & Schwarz at 08:06 CET on Monday, November 16, 2026, 3.20 percent above the Xetra close of Friday, November 13, 2026.

Elevance Health operates a broad health benefits business serving consumers, families and communities. Its offering spans medical, digital, pharmaceutical, behavioral-health and clinical solutions, giving investors exposure to several parts of the healthcare-services market.

The broader US market is tracked by the S&P 500.

More news and analyses on Elevance Health stock.

Disclaimer...
en | US0367521038 | ELEVANCE HEALTH | boerse | 70519642 | bgmi